These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6124623)

  • 1. On the stereospecificity of monoamine oxidase.
    Williams CH
    J Pharm Pharmacol; 1982 Jun; 34(6):386-7. PubMed ID: 6124623
    [No Abstract]   [Full Text] [Related]  

  • 2. Rat heart monoamine oxidase: antagonism between d-amphetamine, oleic and arachidonic acids and monoamine oxidase inhibitors.
    Sen R; Parmar SS; Guha SR
    Proc West Pharmacol Soc; 1979; 22():109-13. PubMed ID: 515037
    [No Abstract]   [Full Text] [Related]  

  • 3. Substrate and inhibitor selectivity of human heart monoamine oxidase.
    Parkinson D; Callingham BA
    Biochem Pharmacol; 1979 May; 28(10):1639-43. PubMed ID: 38793
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions of monoamine oxidase with substrates and inhibitors.
    Dostert PL; Strolin Benedetti M; Tipton KF
    Med Res Rev; 1989; 9(1):45-89. PubMed ID: 2644497
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of monoamine oxidase by amphetamine and related compounds.
    Mantle TJ; Tipton KF; Garrett NJ
    Biochem Pharmacol; 1976 Sep; 25(18):2073-7. PubMed ID: 985546
    [No Abstract]   [Full Text] [Related]  

  • 6. Discovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistry.
    Cagide F; Silva T; Reis J; Gaspar A; Borges F; Gomes LR; Low JN
    Chem Commun (Camb); 2015 Feb; 51(14):2832-5. PubMed ID: 25579652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of some pyridazinylacetic acid derivatives as a novel class of monoamine oxidase-A inhibitors.
    Khattab SN; Bekhit AA; El-Faham A; El Massry AM; Amer A
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1717-21. PubMed ID: 19043245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase. Inhibition by amphetamine, mexiletine and other drugs.
    Clarke DE; Lyles GA; Callingham BA
    Biochem Pharmacol; 1982 Jan; 31(1):27-35. PubMed ID: 7059347
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of mechanism-based inactivators to probe the mechanism of monoamine oxidase.
    Silverman RB
    Biochem Soc Trans; 1991 Feb; 19(1):201-6. PubMed ID: 2037149
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.
    Baumanis EA; Kalnina IE; Moskvitina TA; Gorkin VZ
    Biochem Pharmacol; 1977 Jun; 26(11):1059-63. PubMed ID: 18152
    [No Abstract]   [Full Text] [Related]  

  • 11. [Amine binding with mitochondrial monoamine oxidase and the selective inhibition of enzymatic activity by pyridine derivatives].
    Severina IS; Kozlova IS
    Biokhimiia; 1973; 38(5):1076-82. PubMed ID: 4780966
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of acetylcholine on monoamine oxidase.
    Mohammed YS; Osman MY; Mahfouz MM
    Biochem Pharmacol; 1976 Jul; 25(14):1665-7. PubMed ID: 942467
    [No Abstract]   [Full Text] [Related]  

  • 13. A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S; Cirilli R; Ferretti R; Sanna ML
    Bioorg Med Chem; 2010 Feb; 18(3):1273-9. PubMed ID: 20045650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.
    Eade NR; Renton KW
    Biochem Pharmacol; 1970 Jul; 19(7):2243-50. PubMed ID: 5520372
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitors alter the spectrum and redox properties of monoamine oxidase A.
    Ramsay RR; Hunter DJ
    Biochim Biophys Acta; 2002 Dec; 1601(2):178-84. PubMed ID: 12445480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based inhibitors of monoamine oxidase.
    Richards LE; Burger A
    Prog Drug Res; 1986; 30():205-19. PubMed ID: 3544044
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychoactive drug effects and substrate-specificity in intact mitochondrial monoamine oxidase from brain [proceedings].
    Gabay S; Achee FM
    Psychopharmacol Bull; 1977 Jan; 13(1):45-6. PubMed ID: 13452
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase substrates and substrate affinity.
    Domino EF
    Schizophr Bull; 1980; 6(2):292-7. PubMed ID: 6769148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC-based bioactivity profiling of plant extracts: a kinetic assay for the identification of monoamine oxidase-A inhibitors using human recombinant monoamine oxidase-A.
    Dittmann K; Riese U; Hamburger M
    Phytochemistry; 2004 Nov; 65(21):2885-91. PubMed ID: 15501256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic behavior and reversible inhibition of monoamine oxidases--enzymes that many want dead.
    Tipton KF; Davey GP; McDonald AG
    Int Rev Neurobiol; 2011; 100():43-64. PubMed ID: 21971002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.